142 related articles for article (PubMed ID: 9731600)
1. Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: a prospective study.
Cullinane M; Wainwright R; Brown A; Monaghan M; Markus HS
Stroke; 1998 Sep; 29(9):1810-5. PubMed ID: 9731600
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic embolisation in non-valvular atrial fibrillation and its relationship to anticoagulation therapy.
Tinkler K; Cullinane M; Kaposzta Z; Markus HS
Eur J Ultrasound; 2002 Jun; 15(1-2):21-7. PubMed ID: 12044849
[TBL] [Abstract][Full Text] [Related]
3. Temporal variability of asymptomatic embolization in carotid artery stenosis and optimal recording protocols.
Molloy J; Khan N; Markus HS
Stroke; 1998 Jun; 29(6):1129-32. PubMed ID: 9626283
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.
Gage BF; Cardinalli AB; Albers GW; Owens DK
JAMA; 1995 Dec; 274(23):1839-45. PubMed ID: 7500532
[TBL] [Abstract][Full Text] [Related]
5. Incidence of new thromboembolic stroke in persons 62 years and older with chronic atrial fibrillation treated with warfarin versus aspirin.
Aronow WS; Ahn C; Kronzon I; Gutstein H
J Am Geriatr Soc; 1999 Mar; 47(3):366-8. PubMed ID: 10078902
[TBL] [Abstract][Full Text] [Related]
6. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
7. Attitudes of Japanese cardiologists toward anticoagulation for nonvalvular atrial fibrillation and reasons for its underuse.
Inoue H; Nozawa T; Okumura K; Iwasa A; Lee JD; Shimizu A; Hayano M; Yano K
Circ J; 2004 May; 68(5):417-21. PubMed ID: 15118281
[TBL] [Abstract][Full Text] [Related]
8. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
9. [A study on the recurrence of ischemic stroke in nonvalvular atrial fibrillation].
Luo M; Xie RM; Quan HB; Hu Y; Cai YY
Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):637-40. PubMed ID: 17967232
[TBL] [Abstract][Full Text] [Related]
10. [Isolated atrial fibrillation. The risk of embolism and its prevention].
Fouchard J; Le F; Py A; Guérin F
Presse Med; 1992 Jun; 21(24):1117-22. PubMed ID: 1387952
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study).
Asinger RW; Koehler J; Pearce LA; Zabalgoitia M; Blackshear JL; Fenster PE; Strauss R; Hess D; Pennock GD; Rothbart RM; Halperin JL
J Am Soc Echocardiogr; 1999 Dec; 12(12):1088-96. PubMed ID: 10588785
[TBL] [Abstract][Full Text] [Related]
12. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
13. Consideration of clinical variables for choosing new anticoagulant alternatives to warfarin for the management of non-valvular atrial fibrillation.
Lu Y; Branstad R; Karim RM; Asinger RW
J Clin Pharm Ther; 2014 Dec; 39(6):628-36. PubMed ID: 25252149
[TBL] [Abstract][Full Text] [Related]
14. Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillation.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):685-9. PubMed ID: 9307554
[TBL] [Abstract][Full Text] [Related]
15. Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial.
Sato H; Ishikawa K; Kitabatake A; Ogawa S; Maruyama Y; Yokota Y; Fukuyama T; Doi Y; Mochizuki S; Izumi T; Takekoshi N; Yoshida K; Hiramori K; Origasa H; Uchiyama S; Matsumoto M; Yamaguchi T; Hori M;
Stroke; 2006 Feb; 37(2):447-51. PubMed ID: 16385088
[TBL] [Abstract][Full Text] [Related]
16. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259
[TBL] [Abstract][Full Text] [Related]
17. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
[TBL] [Abstract][Full Text] [Related]
18. Effect of warfarin versus aspirin on the incidence of new thromboembolic stroke in older persons with chronic atrial fibrillation and abnormal and normal left ventricular ejection fraction.
Aronow WS; Ahn C; Kronzon I; Gutstein H
Am J Cardiol; 2000 Apr; 85(8):1033-5. PubMed ID: 10760353
[No Abstract] [Full Text] [Related]
19. Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation.
Yasaka M; Yamaguchi T
CNS Drugs; 2001; 15(8):623-31. PubMed ID: 11524034
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation and atrial fibrillation.
Atwood JE; Albers GW
Herz; 1993 Feb; 18(1):27-38. PubMed ID: 8454250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
